Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata

被引:13
作者
Yeo, In Kwon [1 ]
Ko, Bun Jung [1 ]
No, Yeon A. [1 ]
Lim, Ee Seok [2 ]
Park, Kui Young [1 ]
Li, Kapsok [1 ]
Kim, Beom Joon [1 ]
Seo, Seoiag Jun [1 ]
Kim, Myeung Nam [1 ]
Hong, Chang Kwun [1 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul, South Korea
[2] Theme Skin Clin, Seoul, South Korea
关键词
Alopecia areata; Cyclosporine; Pulse therapy; METHYLPREDNISOLONE THERAPY; PREDNISONE; UPDATE;
D O I
10.5021/ad.2015.27.6.676
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Severe alopecia areata (AA) is resistant to conventional treatment. Although systemic oral,corticosteroids are an effective treatment for patients with severe AA, those drugs have many adverse effects. Corticosteroid pulse therapy has been introduced to increase therapeutic effects and reduce adverse effects. However, the treatment modality in severe AA is still controversial. Objective: To evaluate the effectiveness of corticosteroid pulse therapy in patients with severe AA compared with treatment with oral cyclosporine with corticosteroid. Methods: A total of 82 patients with severe AA were treated with corticosteroid pulse therapy, and 60 patients were treated with oral cyclosporine with corticosteroid. Both groups were retrospectively evaluated for therapeutic efficacy according to AA type and disease duration. Results: In 82 patients treated with corticosteroid pulse therapy, 53 (64.6%) were good responders (>50% hair regrowth). Patients with the plurifocal (PF) type of AA and those with a short disease duration (<= 3 months) showed better responses. In 60 patients treated with oral cyclosporine with corticosteroid, 30 (50.0%) patients showed a good response. The AA type or disease duration, however, did not significantly affect the response to treatment. Conclusion: Corticosteroid pulse therapy may be a better treatment option than combination therapy in severe AA patients with the PF type.
引用
收藏
页码:676 / 681
页数:6
相关论文
共 26 条
[1]  
Assouly P, 2003, ANN DERMATOL VENER, V130, P326
[2]  
BURTON JL, 1975, ACTA DERM-VENEREOL, V55, P493
[3]  
Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO
[4]  
2-M
[5]   Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays [J].
Ferron, GM ;
Pyszczynski, NA ;
Jusko, WJ .
TRANSPLANTATION, 1998, 65 (09) :1203-1209
[6]   ALOPECIA-AREATA - A REVIEW OF THERAPY, EFFICACY, SAFETY, AND MECHANISM [J].
FIEDLER, VC .
ARCHIVES OF DERMATOLOGY, 1992, 128 (11) :1519-1529
[7]   Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients [J].
Friedli, A ;
Labarthe, MP ;
Engelhardt, E ;
Feldmann, R ;
Salomon, D ;
Saurat, JH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (04) :597-602
[8]   ORAL CYCLOSPORINE IN THE TREATMENT OF INFLAMMATORY AND NONINFLAMMATORY DERMATOSES - A CLINICAL AND IMMUNOPATHOLOGIC ANALYSIS [J].
GUPTA, AK ;
ELLIS, CN ;
NICKOLOFF, BJ ;
GOLDFARB, MT ;
HO, VC ;
ROCHER, LL ;
GRIFFITHS, CEM ;
COOPER, KD ;
VOORHEES, JJ .
ARCHIVES OF DERMATOLOGY, 1990, 126 (03) :339-350
[9]   Guidelines for the management of alopecia areata [J].
Hull, SPM ;
Wood, ML ;
Hutchinson, PE ;
Sladden, M ;
Messenger, AG .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) :692-699
[10]   Prognostic factors in methylprednisolone pulse therapy for alopecia areata [J].
Im, Myung ;
Lee, Sang Sin ;
Lee, Young ;
Kim, Chang Deok ;
Seo, Young Joon ;
Lee, Jeung Hoon ;
Park, Jang Kyu .
JOURNAL OF DERMATOLOGY, 2011, 38 (08) :767-772